| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 353.266 | 665.108 | 917.576 | 1.287.334 | 1.387.737 |
| Total Income - EUR | - | - | - | - | - | 353.543 | 666.364 | 948.035 | 1.307.604 | 1.398.334 |
| Total Expenses - EUR | - | - | - | - | - | 339.336 | 576.692 | 912.275 | 1.183.795 | 1.264.143 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.207 | 89.673 | 35.760 | 123.809 | 134.191 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.684 | 71.413 | 28.544 | 100.724 | 115.214 |
| Employees | - | - | - | - | - | 5 | 7 | 11 | 16 | 17 |
Check the financial reports for the company - Touchpoint Medical Nv Beveren ( Melsele) Belgia Su
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 26.994 | 32.970 | 48.590 | 32.743 | 25.711 |
| Current Assets | - | - | - | - | - | 366.618 | 1.997.069 | 1.218.351 | 1.022.276 | 682.213 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 366.618 | 1.001.707 | 1.057.269 | 806.696 | 559.845 |
| Cash | - | - | - | - | - | 0 | 995.362 | 161.082 | 215.580 | 122.367 |
| Shareholders Funds | - | - | - | - | - | 8.684 | 79.904 | 108.697 | 209.091 | 323.136 |
| Social Capital | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | - | 366.585 | 1.919.601 | 1.123.027 | 789.498 | 339.160 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6210 - 6210" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Touchpoint Medical Nv Beveren ( Melsele) Belgia Sucursala Cluj-Napoca